Overview

Carboplatin in Castration-resistant Prostate Cancer

Status:
Terminated
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Open label, non-randomised phase II clinical pilot study
Phase:
Phase 2
Details
Lead Sponsor:
Aurelius Omlin
Collaborators:
Teva Pharma
University Hospital, Zürich
Treatments:
Carboplatin